AgenT
Paris
About AgenT
AgenT is a life sciences company on a mission to defeat Alzheimer’s disease by targeting the silent phase. By combining multi-omics assays with advanced machine learning techniques, we found new blood biomarkers deregulated from the earliest stages of the disease. Using this proprietary database, we are developing an accurate blood diagnosis and the next generation of precision therapies to treat Alzheimer’s.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $3.9M
- Funding stage: Seed
- Last round: Seed (Jul 2021)
- Website: agent-biotech.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Life Science, Neuroscience
Social Profiles
Canonical: https://fsome.com/organization/agent-110567 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.